[Freedreno] Adreno 200 / AMD 430 on linux-3.19

Enrico Weigelt, metux IT consult weigelt at melag.de
Wed Mar 4 00:30:18 PST 2015


Am 03.03.2015 um 19:27 schrieb Rob Clark:

 > well, a2xx doesn't really get too much love these days on the
> userspace side of things either, although that is probably strongly
> related to my lack of motivation to deal w/ an old 2.6.x kernel ;-)

Well, I already have the fsl-kgsl stuff on 3.10.12 - Robert and his
boys did a nice here (and reading their patch comments sometimes is
quite a fun ;-)). ...

The dirty hacks to the blob driver working are quite scary

I've rebased all the stuff to 3.19, but didn't get it working yet,
eg. there had been deeper changes in the DRM internals which the
fsl-kgsl still needs to be adapted for.

> Upstream drm/msm support for a2xx would be really nice.

For us over here, it's a quite important thing. As we're building
medical devices, we need really good reproducability/tracability.
Some horribly coded proprietary blob doesn't fit in here.
(we haven't sorted out, whether we could use it all, yet).

The alternative would be dropping GL entirely, which also means
loosing QML (well, I'm not a fan of QML anyways, but the GUI folks
usually like it).


So, to get back to the original problem: how can I help to
improve the situation ?


cu
--
Enrico Weigelt, metux IT consult
+49-151-27565287
[IDS]

MELAG Medizintechnik oHG Sitz Berlin Registergericht AG Charlottenburg HRA 21333 B

Wichtiger Hinweis: Diese Nachricht kann vertrauliche oder nur für einen begrenzten Personenkreis bestimmte Informationen enthalten. Sie ist ausschließlich für denjenigen bestimmt, an den sie gerichtet worden ist. Wenn Sie nicht der Adressat dieser E-Mail sind, dürfen Sie diese nicht kopieren, weiterleiten, weitergeben oder sie ganz oder teilweise in irgendeiner Weise nutzen. Sollten Sie diese E-Mail irrtümlich erhalten haben, so benachrichtigen Sie bitte den Absender, indem Sie auf diese Nachricht antworten. Bitte löschen Sie in diesem Fall diese Nachricht und alle Anhänge, ohne eine Kopie zu behalten.
Important Notice: This message may contain confidential or privileged information. It is intended only for the person it was addressed to. If you are not the intended recipient of this email you may not copy, forward, disclose or otherwise use it or any part of it in any form whatsoever. If you received this email in error please notify the sender by replying and delete this message and any attachments without retaining a copy.


More information about the Freedreno mailing list